{"id":"W1924457352","doi":"10.1111/j.1468-3083.2012.04705.x","title":"Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open‐label extension trial of the interleukin‐12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Mace; Adverse effect; Internal medicine; Interim analysis; Clinical trial; Incidence (geometry); Population; Surgery; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0120484,0.0002989275,0.005030158,0.0003368165,0.0001499018,0.00001165026,0.00110386,0.0004458808,0.00002972542],"category_scores_gemma":[0.003829063,0.0001627417,0.0004246678,0.0002063232,0.000873108,0.0002606831,0.001529998,0.0005768911,9.328014e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001175722,"about_ca_system_score_gemma":0.00006965407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001429544,"about_ca_topic_score_gemma":0.00006605821,"domain_scores_codex":[0.9728681,0.02233801,0.004010438,0.000422991,0.00008635192,0.0002741478],"domain_scores_gemma":[0.9898268,0.00556667,0.003929929,0.0005028523,0.00008475039,0.00008897097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.940331,0.001296889,0.008863254,0.000006946302,0.01284824,0.00001173671,0.001389356,0.00001370796,0.02542449,0.0001432617,0.0003090991,0.009361993],"study_design_scores_gemma":[0.9383336,0.0005127398,0.03980638,0.0002010757,0.01533547,0.0003682793,0.0001986103,0.0004989145,0.00375958,0.000455084,0.0003276535,0.0002026374],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98814,0.006763728,0.0001170329,0.002286961,0.0009806916,0.0009154999,0.0007241653,0.000003470884,0.00006839428],"genre_scores_gemma":[0.9971645,0.001899745,0.0002846502,0.0003287753,0.0001383507,0.000004185364,0.0001157936,0.00001516973,0.00004880038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03094313,"threshold_uncertainty_score":0.6636413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1295731250105945,"score_gpt":0.414242384369461,"score_spread":0.2846692593588664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}